Show simple item record

dc.contributor.authorBhargava, Pankaj
dc.contributor.authorGammon, David C.
dc.contributor.authorMcCormick, Michael J.
dc.date2022-08-11T08:08:06.000
dc.date.accessioned2022-08-23T15:42:29Z
dc.date.available2022-08-23T15:42:29Z
dc.date.issued2003-12-24
dc.date.submitted2010-03-10
dc.identifier.citationCancer. 2004 Jan 1;100(1):211-2. <a href="http://dx.doi.org/10.1002/cncr.11901">Link to article on publisher's site</a>
dc.identifier.issn0008-543X (Linking)
dc.identifier.doi10.1002/cncr.11901
dc.identifier.pmid14692042
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26859
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=14692042&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1002/cncr.11901
dc.subjectAnaphylaxis
dc.subjectAntineoplastic Agents
dc.subjectuse
dc.subjectColonic Neoplasms
dc.subjectDesensitization, Immunologic
dc.subjectDrug Hypersensitivity
dc.subjectFemale
dc.subjectHumans
dc.subjectMiddle Aged
dc.subjectOrganoplatinum Compounds
dc.subjecteffects
dc.subjectPharmacy and Pharmaceutical Sciences
dc.titleHypersensitivity and idiosyncratic reactions to oxaliplatin
dc.typeJournal Article
dc.source.journaltitleCancer
dc.source.volume100
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/clinpharm_pp/6
dc.identifier.contextkey1212965
dc.identifier.submissionpathclinpharm_pp/6
dc.contributor.departmentDivision of Hematology/Oncology
dc.contributor.departmentDivision of Pulmonary, Allergy and Critical Care Medicine
dc.contributor.departmentDepartment of Pharmacy
dc.source.pages211-2


This item appears in the following Collection(s)

Show simple item record